Anabolic bone agent
Also called: anabolic agents
What it means
Anabolic bone agents are medications, like teriparatide, abaloparatide, and romosozumab, that stimulate the body to actively build new bone rather than just slowing bone loss.
Understanding how these drugs work can help you have informed conversations with your doctor about building, not just preserving, your bone strength.
Anabolic bone agents are a category of osteoporosis medications designed to build new bone, rather than simply slowing bone breakdown. Teriparatide (Forteo) and abaloparatide (Tymlos) are daily injections based on parathyroid hormone; given this way, they stimulate osteoblasts to form bone. Romosozumab (Evenity) works differently, by blocking sclerostin, a signaling molecule that normally tells bone-forming cells to slow down. Because of this, romosozumab is described as conceptually similar to what mechanical loading does in the body.
These medications tend to produce larger bone density gains than antiresorptive drugs, which is why they're typically reserved for people at higher risk of fracture. They're also time-limited by design, usually used for a course of 12 to 24 months. The gains made during that window aren't permanent on their own, so standard practice is to follow an anabolic course with an antiresorptive medication to help maintain what was built. Romosozumab also carries a cardiovascular warning, which makes careful patient selection important.
If you're on one of these medications, or your doctor has mentioned one, decisions about starting, stopping, or sequencing treatment belong to your prescriber, who can weigh your personal risk factors and history.
How sure is this?
Graded Strong Clinical Evidence: Supported by multiple well-designed clinical studies in humans. Read each study with its grade in mind. One study is a piece of the picture, not the whole of it.
Where the Academy teaches it
This page is the short version. The lessons teach it in full, with the context around it and a quiz to lock it in.
Questions people ask about this
Bone medications generally work in one of two ways: they either slow down the cells that break down old bone (antiresorptives), or they actively stimulate the cells that build new bone (anabolics). Which family your drug belongs to tells you a lot about what it can realistically do, and that's worth asking your prescriber about directly.
Read the full answer →Osteoporosis generally can't be fully "reversed" back to young, healthy bone, but it can be meaningfully improved. The remodeling system that builds and removes bone is still working in osteoporosis — it's just shifted toward loss — so rebalancing it through loading, nutrition, hormones, and sometimes medication can help rebuild some density and strength over time.
Read the full answer →That's a decision for you and your prescriber, not something OsteoStrong changes. Medication and mechanical loading work on different parts of the same system — your drug manages the chemical signalling of bone remodeling, while loading supplies a mechanical stimulus along with muscle, balance and coordination. They're meant to work alongside each other, not replace one another.
Read the full answer →Related words
Antiresorptive medications, like bisphosphonates and denosumab, slow down the cells that break down old bone,…
Sclerostin is a protein made by bone cells called osteocytes that blocks new bone formation; less mechanical strain…
An osteoblast is a cell that builds new bone by laying down fresh bone matrix, working alongside cells that break…
Bone remodeling is the lifelong cycle where cells called osteoclasts remove old bone and osteoblasts build new bone…
A drug holiday is a temporary, prescriber-guided pause from a bisphosphonate medication after several years of use,…
Romosozumab (brand name Evenity) is an anabolic osteoporosis medication given by injection that blocks sclerostin, a…
Education only, not medical advice. Decisions about tests, medications and treatment belong with your own doctor. OsteoStrong does not diagnose, treat or cure any disease.
